Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Medicine (Baltimore) ; 103(8): e37249, 2024 Feb 23.
Article in English | MEDLINE | ID: mdl-38394530

ABSTRACT

BACKGROUND: Intestinal malrotation is an infrequent congenital anomaly primarily observed in neonates, and adult-onset cases are exceedingly rare. Studies on adult congenital intestinal malrotation are limited. METHODS: A case with congenital intestinal malrotation is reported in our study. The clinical data were collected and the treatment process and effect were evaluated. RESULTS: A 45-year-old female who had been experiencing vomiting for over 40 years was admitted to our hospital. According to the result of CT scan, intestinal volvulus accompanied by bowel obstruction was suspected. Then laparoscopic examination was applied to the patient and was ultimately diagnosed with adult congenital intestinal malrotation. We performed Ladd's procedure combined with gastrojejunostomy and Braun anastomosis. The patient recovered well and was successfully discharged from the hospital on the 13th day after surgery. After a 6-month follow-up, the symptom of vomiting was significantly alleviated and body weight was gained for 10 kg. She was very satisfied with the treatment. CONCLUSION: Adult congenital intestinal malrotation is a rare disease that is often misdiagnosed owing to nonspecific clinical manifestations. Therefore, awareness about this condition should be enhanced. Surgery remains the cornerstone of treatment for this disease. Combining gastrojejunostomy and Braun anastomosis with the traditional Ladd procedure can optimize surgical outcomes.


Subject(s)
Digestive System Abnormalities , Gastric Bypass , Intestinal Obstruction , Intestinal Volvulus , Infant, Newborn , Adult , Female , Humans , Middle Aged , Intestinal Volvulus/diagnosis , Intestinal Volvulus/surgery , Intestinal Volvulus/complications , Intestines/surgery , Intestinal Obstruction/surgery , Intestinal Obstruction/complications , Gastric Bypass/adverse effects , Vomiting/complications
2.
Front Pharmacol ; 13: 1096137, 2022.
Article in English | MEDLINE | ID: mdl-36699051

ABSTRACT

PM2.5 is an important environmental problem threatening human health at present, which poses serious harm to human body after inhalation. J. cannabifolia is a traditional Chinese medicine which exhibits anti-inflammatory effect. This study aimed to investigate the inhibitory effect of main phenolic acid components of J. cannabifolia on inflammation caused by PM2.5. Effect of PM2.5 on cell activity and apoptosis were determined by MTT, flow cytometry and calcein AM/PI staining. PHBA, PHPAA, and mixture of PHBA and PHPAA of different concentrations were given to RAW264.7 cells pretreated with PM2.5. The effect of drugs on cellular inflammatory factors was detected by ELISA. The expressions of TLRs related signal pathway at protein and gene levels were detected by western blot and qRT-PCR. The results showed that PM2.5 had no effect on cell activity and apoptosis within the determined concentration range. PHBA and PHPAA could markly inhibit the level of IL-1ß, IL-6, and TNF-α in RAW264.7 cells. Furthermore, the expressions of TLR2, TLR4, MyD88, IRAK1, TRAF6, TAK1, IKKß, and NF-κB induced by PM2.5 were markedly inhibited by PHBA and PHPAA at protein and gene levels. This study demonstrated that PHBA and PHPAA could attenuated inflammation caused by PM2.5 through suppressing TLRs related signal pathway.

3.
PLoS One ; 10(3): e0120950, 2015.
Article in English | MEDLINE | ID: mdl-25786031

ABSTRACT

Curcumin, a principle bioactive component of Curcuma longa L, is well known for its anti-hyperlipidemia effect. However, no holistic metabolic information of curcumin on hyperlipidemia models has been revealed, which may provide us an insight into the underlying mechanism. In the present work, NMR and MS based metabolomics was conducted to investigate the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet (HFD) feeding for 12 weeks. The HFD induced animals were orally administered with curcumin (40, 80 mg/kg) or lovastatin (30 mg/kg, positive control) once a day during the inducing period. Serum biochemistry assay of TC, TG, LDL-c, and HDL-c was conducted and proved that treatment of curcumin or lovastatin can significantly improve the lipid profiles. Subsequently, metabolomics analysis was carried out for urine samples. Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) was employed to investigate the anti-hyperlipidemia effect of curcumin and to detect related potential biomarkers. Totally, 35 biomarkers were identified, including 31 by NMR and nine by MS (five by both). It turned out that curcumin treatment can partially recover the metabolism disorders induced by HFD, with the following metabolic pathways involved: TCA cycle, glycolysis and gluconeogenesis, synthesis of ketone bodies and cholesterol, ketogenesis of branched chain amino acid, choline metabolism, and fatty acid metabolism. Besides, NMR and MS based metabolomics proved to be powerful tools in investigating pharmacodynamics effect of natural products and underlying mechanisms.


Subject(s)
Curcumin/pharmacology , Diet, High-Fat , Hyperlipidemias/metabolism , Hypolipidemic Agents/pharmacology , Metabolome/drug effects , Animals , Biomarkers/metabolism , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Curcuma/chemistry , Curcumin/isolation & purification , Dietary Fats/administration & dosage , Discriminant Analysis , Hyperlipidemias/diagnosis , Hyperlipidemias/etiology , Hyperlipidemias/pathology , Hypolipidemic Agents/isolation & purification , Lipid Metabolism/drug effects , Liver/drug effects , Liver/metabolism , Lovastatin/pharmacology , Magnetic Resonance Spectroscopy , Male , Metabolic Networks and Pathways/drug effects , Mice , Mice, Inbred C57BL , Tandem Mass Spectrometry , Triglycerides/blood
4.
Acta Crystallogr Sect E Struct Rep Online ; 67(Pt 4): o957, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21754222

ABSTRACT

The molecule of the title compound, C(9)H(6)N(2)O(2), is almost planar, with a dihedral angle of 3.0 (9)° between the pyridine and benzene rings.

5.
Nan Fang Yi Ke Da Xue Xue Bao ; 27(7): 987-90, 2007 Jul.
Article in Chinese | MEDLINE | ID: mdl-17666333

ABSTRACT

OBJECTIVE: To investigate the effect of ulinastatin on intestinal mucosal barrier function of rats with obstructive jaundice. METHODS: Seventy-two male SD rats were randomly divided into sham operation, obstructive jaundice, and ulinastatin treatment groups (groups A, B, and C, respectively). In groups B and C, the common bile duct was ligated to induce obstructive jaundice. The rats in group C were given intraperitoneal injection of ulinastatin at the daily dose of 40,000 IU/kg after the operation, while those in groups A and group B received equal amount of normal saline. At 3, 5, 7 and 10 days after the operation, the liver function and plasma endotoxin level were evaluated and measured, and bacterial culture of the mesenteric lymph nodes, liver and spleen was performed. The terminal ileum mucosa was observed under light microscope, and the intestinal villi and mucosal thinckness was examined with image analysis system. RESULTS: The indices relative to the liver function and plasma endotoxin level were higher at different time points of observation in group B than in group A (P<0.01), and were lower in group C than in group B (P<0.01). Plasma endotoxin level was similar between groups A and C 3 days after the operation (P>0.05). The rate of bacterial translocation was higher in group B than in group A and C (P<0.01, P<0.05), but comparable between groups A and C (P>0.05). Intestinal mucosal injury was observed in group B 3 days after operation, and aggravated with the passage of time. The injury was milder in group C. The intestinal villus length and mucosal thickness were greater in groups A and C than in group B (P<0.01 or P<0.05), but comparable between the former two groups 3 days after operation (P>0.05). CONCLUSION: In early stage of obstructive jaundice, the intestinal mucosal barrier may sustain injuries which aggravate with time; ulinastatin has significant effect in protecting the mucosal barrier function especially against early pathological changes.


Subject(s)
Glycoproteins/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/physiopathology , Jaundice, Obstructive/physiopathology , Animals , Bacterial Translocation/drug effects , Endotoxins/blood , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Jaundice, Obstructive/blood , Jaundice, Obstructive/microbiology , Jaundice, Obstructive/pathology , Liver/drug effects , Liver/physiopathology , Male , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...